{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:55Z","timestamp":1790187115496,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nanyang Technology University","award":["Nanyang Technological University Start-Up Grant"],"award-info":[{"award-number":["Nanyang Technological University Start-Up Grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12272-015-0645-0","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T07:10:58Z","timestamp":1439190658000},"page":"1702-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Next-generation antimicrobials: from chemical biology to first-in-class drugs"],"prefix":"10.1007","volume":"38","author":[{"given":"Michelle Lay Teng","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"645_CR1","doi-asserted-by":"crossref","first-page":"e52951","DOI":"10.1371\/journal.pone.0052951","volume":"7","author":"KA Abrahams","year":"2012","unstructured":"Abrahams, K.A., J.A. Cox, V.L. Spivey, N.J. Loman, M.J. Pallen, C. Constantinidou, R. Fernandez, C. Alemparte, M.J. Remuinan, D. Barros, L. Ballell, and G.S. Besra. 2012. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB. PLoS ONE 7: e52951.","journal-title":"PLoS ONE"},{"key":"645_CR2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison, K.R., M.P. Brynildsen, and J.J. Collins. 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216\u2013220.","journal-title":"Nature"},{"key":"645_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","volume":"307","author":"K Andries","year":"2005","unstructured":"Andries, K., P. Verhasselt, J. Guillemont, H.W. G\u00f6hlmann, J.M. Neefs, H. Winkler, J. Van Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V. Jarlier. 2005. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307: 223\u2013227.","journal-title":"Science"},{"key":"645_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMp0804651","volume":"360","author":"CA Arias","year":"2009","unstructured":"Arias, C.A., and B.E. Murray. 2009. Antibiotic-resistant bugs in the 21st century\u2013a clinical super-challenge. New England Journal of Medicine 360: 439\u2013443.","journal-title":"New England Journal of Medicine"},{"key":"645_CR5","doi-asserted-by":"crossref","first-page":"e1001065","DOI":"10.1371\/journal.pbio.1001065","volume":"9","author":"SH Baek","year":"2011","unstructured":"Baek, S.H., A.H. Li, and C.M. Sassetti. 2011. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biology 9: e1001065.","journal-title":"PLoS Biology"},{"key":"645_CR6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","volume":"8","author":"L Ballell","year":"2013","unstructured":"Ballell, L., R.H. Bates, R.J. Young, D. Alvarez-Gomez, E. Alvarez-Ruiz, V. Barroso, D. Blanco, B. Crespo, J. Escribano, R. Gonz\u00e1lez, S. Lozano, S. Huss, A. Santos-Villarejo, J.J. Mart\u00edn-Plaza, A. Mendoza, M.J. Rebollo-Lopez, M. Remui\u00f1an-Blanco, J.L. Lavandera, E. P\u00e9rez-Herran, F.J. Gamo-Benito, J.F. Garc\u00eda-Bustos, D. Barros, J.P. Castro, and N. Cammack. 2013. Fueling open-source drug discovery: 177 Small-molecule leads against tuberculosis. ChemMedChem 8: 313\u2013321.","journal-title":"ChemMedChem"},{"key":"645_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana, B., I. Hallyburton, M.C. Lee, N.R. Norcross, R. Grimaldi, T.D. Otto, W.R. Proto, A.M. Blagborough, S. Meister, G. Wirjanata, A. Ruecker, L.M. Upton, T.S. Abraham, M.J. Almeida, A. Pradhan, A. Porzelle, M.S. Martinez, J.M. Bolscher, A. Woodland, S. Norval, F. Zuccotto, J. Thomas, F. Simeons, L. Stojanovski, M. Osuna-Cabello, P.M. Brock, T.S. Churcher, K.A. Sala, S.E. Zakutansky, M.B. Jimenez-Diaz, L.M. Sanz, J. Riley, R. Basak, M. Campbell, V.M. Avery, R.W. Sauerwein, K.J. Dechering, R. Noviyanti, B. Campo, J.A. Frearson, I. Angulo-Barturen, S. Ferrer-Bazaga, F.J. Gamo, P.G. Wyatt, D. Leroy, P. Siegl, M.J. Delves, D.E. Kyle, S. Wittlin, J. Marfurt, R.N. Price, R.E. Sinden, E.A. Winzeler, S.A. Charman, L. Bebrevska, D.W. Gray, S. Campbell, A.H. Fairlamb, P.A. Willis, J.C. Rayner, D.A. Fidock, K.D. Read, and I.H. Gilbert. 2015. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522: 315\u2013320.","journal-title":"Nature"},{"key":"645_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.3823","volume":"21","author":"CE Barry 3rd","year":"2015","unstructured":"Barry 3rd, C.E. 2015. Timing is everything for compassionate use of delamanid. Nature Medicine 21: 211.","journal-title":"Nature Medicine"},{"key":"645_CR9","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1371\/journal.pntd.0000384","volume":"3","author":"E Bettiol","year":"2009","unstructured":"Bettiol, E., M. Samanovic, A.S. Murkin, J. Raper, F. Buckner, and A. Rodriguez. 2009. Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening. PLOS Neglected Tropical Diseases 3: e384.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"645_CR10","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","volume":"56","author":"HW Boucher","year":"2013","unstructured":"Boucher, H.W., G.H. Talbot, D.K. Benjamin Jr, J. Bradley, R.J. Guidos, R.N. Jones, B.E. Murray, R.A. Bonomo, D. Gilbert, and Infectious Diseases Society of A. 2013. 10 \u00d7 \u201820 Progress\u2013development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America. Clinical Infectious Diseases 56: 1685\u20131694.","journal-title":"Clinical Infectious Diseases"},{"key":"645_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H.W., G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical Infectious Diseases 48: 1\u201312.","journal-title":"Clinical Infectious Diseases"},{"key":"645_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature07772","volume":"458","author":"S Brinster","year":"2009","unstructured":"Brinster, S., G. Lamberet, B. Staels, P. Trieu-Cuot, A. Gruss, and C. Poyart. 2009. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458: 83\u201386.","journal-title":"Nature"},{"key":"645_CR13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrmicro1955","volume":"6","author":"SA Brown","year":"2008","unstructured":"Brown, S.A., K.L. Palmer, and M. Whiteley. 2008. Revisiting the host as a growth medium. Nature Reviews Microbiology 6: 657\u2013666.","journal-title":"Nature Reviews Microbiology"},{"key":"645_CR14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.chembiol.2004.05.001","volume":"11","author":"L Burdine","year":"2004","unstructured":"Burdine, L., and T. Kodadek. 2004. Target identification in chemical genetics: The (often) missing link. Chemistry & Biology 11: 593\u2013597.","journal-title":"Chemistry & Biology"},{"key":"645_CR15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/17460441.2011.602063","volume":"6","author":"JM Bustamante","year":"2011","unstructured":"Bustamante, J.M., H.J. Park, R.L. Tarleton, and The Chagas Drug Discovery Consortium. 2011. Report of the 2nd Chagas Drug Discovery Consortium meeting, held on 3 November 2010; Atlanta GA, USA. Expert Opinion on Drug Discovery 6: 965\u2013973.","journal-title":"Expert Opinion on Drug Discovery"},{"key":"645_CR16","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1371\/journal.pntd.0000740","volume":"4","author":"AM Canavaci","year":"2010","unstructured":"Canavaci, A.M., J.M. Bustamante, A.M. Padilla, C.M. Perez Brandan, L.J. Simpson, D. Xu, C.L. Boehlke, and R.L. Tarleton. 2010. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLOS Neglected Tropical Diseases 4: e740.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"645_CR17","doi-asserted-by":"crossref","first-page":"e14275","DOI":"10.1371\/journal.pone.0014275","volume":"5","author":"R Chattopadhyay","year":"2010","unstructured":"Chattopadhyay, R., S. Velmurugan, C. Chakiath, L. Andrews Donkor, W. Milhous, J.W. Barnwell, W.E. Collins, and S.L. Hoffman. 2010. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS ONE 5: e14275.","journal-title":"PLoS ONE"},{"key":"645_CR18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.4155\/fmc.10.223","volume":"2","author":"T Christophe","year":"2010","unstructured":"Christophe, T., F. Ewann, H.K. Jeon, J. Cechetto, and P. Brodin. 2010. High-content imaging of Mycobacterium tuberculosis-infected macrophages: An in vitro model for tuberculosis drug discovery. Future Medicinal Chemistry 2: 1283\u20131293.","journal-title":"Future Medicinal Chemistry"},{"key":"645_CR19","doi-asserted-by":"crossref","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","volume":"5","author":"T Christophe","year":"2009","unstructured":"Christophe, T., M. Jackson, H.K. Jeon, D. Fenistein, M. Contreras-Dominguez, J. Kim, A. Genovesio, J.P. Carralot, F. Ewann, E.H. Kim, S.Y. Lee, S. Kang, M.J. Seo, E.J. Park, H. Skovierov\u00e1, H. Pham, G. Riccardi, J.Y. Nam, L. Marsollier, M. Kempf, M.L. Joly-Guillou, T. Oh, W.K. Shin, Z. No, U. Nehrbass, R. Brosch, S.T. Cole, and P. Brodin. 2009. High content screening identifies decaprenyl-phosphoribose 2\u2032 epimerase as a target for intracellular antimycobacterial inhibitors. PLoS Pathogens 5: e1000645.","journal-title":"PLoS Pathogens"},{"key":"645_CR20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.339.6116.130","volume":"339","author":"J Cohen","year":"2013","unstructured":"Cohen, J. 2013. Infectious disease. Approval of novel TB drug celebrated\u2013with restraint. Science 339: 130.","journal-title":"Science"},{"key":"645_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","volume":"393","author":"ST Cole","year":"1998","unstructured":"Cole, S.T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead, and B.G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537\u2013544.","journal-title":"Nature"},{"key":"645_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0163-7827(02)00007-3","volume":"41","author":"JE Cronan Jr","year":"2002","unstructured":"Cronan Jr, J.E., and G.L. Waldrop. 2002. Multi-subunit acetyl-CoA carboxylases. Progress in Lipid Research 41: 407\u2013435.","journal-title":"Progress in Lipid Research"},{"key":"645_CR23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/1087057109335749","volume":"14","author":"GJ Crowther","year":"2009","unstructured":"Crowther, G.J., A.J. Napuli, A.P. Thomas, D.J. Chung, K.V. Kovzun, D.J. Leibly, L.J. Castaneda, J. Bhandari, C.J. Damman, R. Hui, W.G. Hol, F.S. Buckner, C.L. Verlinde, Z. Zhang, E. Fan, and W.C. van Voorhis. 2009. Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligands. Journal of Biomolecular Screening 14: 700\u2013707.","journal-title":"Journal of Biomolecular Screening"},{"key":"645_CR24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/138945009787581177","volume":"10","author":"AK Cruz","year":"2009","unstructured":"Cruz, A.K., J.S. de Toledo, M. Falade, M.C. Terrao, S. Kamchonwongpaisan, D.E. Kyle, and C. Uthaipibull. 2009. Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: A review. Current Drug Targets 10: 178\u2013192.","journal-title":"Current Drug Targets"},{"key":"645_CR25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.chembiol.2010.02.010","volume":"17","author":"A D\u2019Onofrio","year":"2010","unstructured":"D\u2019Onofrio, A., J.M. Crawford, E.J. Stewart, K. Witt, E. Gavrish, S. Epstein, J. Clardy, and K. Lewis. 2010. Siderophores from neighboring organisms promote the growth of uncultured bacteria. Chemistry & Biology 17: 254\u2013264.","journal-title":"Chemistry & Biology"},{"key":"645_CR26","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0140-6736(14)62002-X","volume":"385","author":"R Dawson","year":"2015","unstructured":"Dawson, R., A.H. Diacon, D. Everitt, C. van Niekerk, P.R. Donald, D.A. Burger, R. Schall, M. Spigelman, A. Conradie, K. Eisenach, A. Venter, P. Ive, L. Page-Shipp, E. Variava, K. Reither, N.E. Ntinginya, A. Pym, F. von Groote-Bidlingmaier, and C.M. Mendel. 2015. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8\u00a0weeks of antituberculosis treatment: A phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet 385: 1738\u20131747.","journal-title":"Lancet"},{"key":"645_CR27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1146\/annurev.micro.50.1.791","volume":"50","author":"G Deckers-Hebestreit","year":"1996","unstructured":"Deckers-Hebestreit, G., and K. Altendorf. 1996. The F0F1-type ATP synthases of bacteria: Structure and function of the F0 complex. Annual Review of Microbiology 50: 791\u2013824.","journal-title":"Annual Review of Microbiology"},{"key":"645_CR28","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.1118370109","volume":"109","author":"ER Derbyshire","year":"2012","unstructured":"Derbyshire, E.R., M. Prudencio, M.M. Mota, and J. Clardy. 2012. Liver-stage malaria parasites vulnerable to diverse chemical scaffolds. Proceedings of the National Academy of Sciences USA 109: 8511\u20138516.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(12)61080-0","volume":"380","author":"AH Diacon","year":"2012","unstructured":"Diacon, A.H., R. Dawson, F. von Groote-Bidlingmaier, G. Symons, A. Venter, P.R. Donald, C. van Niekerk, D. Everitt, H. Winter, P. Becker, C.M. Mendel, and M.K. Spigelman. 2012. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: A randomised trial. Lancet 380: 986\u2013993.","journal-title":"Lancet"},{"key":"645_CR30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/fmb.11.26","volume":"6","author":"T Dick","year":"2011","unstructured":"Dick, T., and D. Young. 2011. How antibacterials really work: Impact on drug discovery. Future Microbiology 6: 603\u2013604.","journal-title":"Future Microbiology"},{"key":"645_CR31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A.M., F. Nosten, P. Yi, D. Das, A.P. Phyo, J. Tarning, K.M. Lwin, F. Ariey, W. Hanpithakpong, S.J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S.S. An, S. Yeung, P. Singhasivanon, N.P. Day, N. Lindegardh, D. Socheat, and N.J. White. 2009. Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 361: 455\u2013467.","journal-title":"New England Journal of Medicine"},{"key":"645_CR32","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/AAC.01777-09","volume":"54","author":"JC Engel","year":"2010","unstructured":"Engel, J.C., K.K. Ang, S. Chen, M.R. Arkin, J.H. McKerrow, and P.S. Doyle. 2010. Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas\u2019 disease. Antimicrobial Agents and Chemotherapy 54: 3326\u20133334.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","volume":"20","author":"MA Farha","year":"2013","unstructured":"Farha, M.A., C.P. Verschoor, D. Bowdish, and E.D. Brown. 2013. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chemistry & Biology 20: 1168\u20131178.","journal-title":"Chemistry & Biology"},{"key":"645_CR34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057114556236","volume":"20","author":"J Faria","year":"2015","unstructured":"Faria, J., C.B. Moraes, R. Song, B.S. Pascoalino, N. Lee, J.L. Siqueira-Neto, D.J. Cruz, T. Parkinson, J.R. Ioset, A. Cordeiro-da-Silva, and L.H. Freitas-Junior. 2015. Drug discovery for human african trypanosomiasis: Identification of novel scaffolds by the newly developed HTS SYBR green assay for Trypanosoma brucei. Journal of Biomolecular Screening 20: 70\u201381.","journal-title":"Journal of Biomolecular Screening"},{"key":"645_CR35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","volume":"81","author":"LS Filardi","year":"1987","unstructured":"Filardi, L.S., and Z. Brener. 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81: 755\u2013759.","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"645_CR36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach, M.A., and C.T. Walsh. 2009. Antibiotics for emerging pathogens. Science 325: 1089\u20131093.","journal-title":"Science"},{"key":"645_CR37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","volume":"2","author":"LH Freitas-Junior","year":"2012","unstructured":"Freitas-Junior, L.H., E. Chatelain, H.A. Kim, and J.L. Siqueira-Neto. 2012. Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it? Int J Parasitol Drugs Drug Resist 2: 11\u201319.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"645_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo, F.J., L.M. Sanz, J. Vidal, C. de Cozar, E. Alvarez, J.L. Lavandera, D.E. Vanderwall, D.V. Green, V. Kumar, S. Hasan, J.R. Brown, C.E. Peishoff, L.R. Cardon, and J.F. Garcia-Bustos. 2010. Thousands of chemical starting points for antimalarial lead identification. Nature 465: 305\u2013310.","journal-title":"Nature"},{"key":"645_CR39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1749-6632.1960.tb20108.x","volume":"88","author":"ED Garber","year":"1960","unstructured":"Garber, E.D. 1960. The host as a growth medium. Annals of the New York Academy of Sciences 88: 1187\u20131194.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"645_CR40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde, W.A., A.A. Shelat, D. Bouck, S. Duffy, G.J. Crowther, P.H. Davis, D.C. Smithson, M. Connelly, J. Clark, F. Zhu, M.B. Jim\u00e9nez-D\u00edaz, M.S. Martinez, E.B. Wilson, A.K. Tripathi, J. Gut, E.R. Sharlow, I. Bathurst, F. El Mazouni, J.W. Fowble, I. Forquer, P.L. McGinley, S. Castro, I. Angulo-Barturen, S. Ferrer, P.J. Rosenthal, J.L. Derisi, D.J. Sullivan, J.S. Lazo, D.S. Roos, M.K. Riscoe, M.A. Phillips, P.K. Rathod, W.C. Van Voorhis, V.M. Avery, and R.K. Guy. 2010. Chemical genetics of Plasmodium falciparum. Nature 465: 311\u2013315.","journal-title":"Nature"},{"key":"645_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1368-7646(98)80026-5","volume":"1","author":"RM Hall","year":"1998","unstructured":"Hall, R.M., and C.M. Collis. 1998. Antibiotic resistance in gram-negative bacteria: The role of gene cassettes and integrons. Drug Resistance Updates 1: 109\u2013119.","journal-title":"Drug Resistance Updates"},{"key":"645_CR42","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1038\/ncomms7715","volume":"6","author":"PS Hameed","year":"2015","unstructured":"Hameed, P.S., S. Solapure, V. Patil, P.P. Henrich, P.A. Magistrado, S. Bharath, K. Murugan, P. Viswanath, J. Puttur, A. Srivastava, E. Bellale, V. Panduga, G. Shanbag, D. Awasthy, S. Landge, S. Morayya, K. Koushik, R. Saralaya, A. Raichurkar, N. Rautela, N. Roy Choudhury, A. Ambady, R. Nandishaiah, J. Reddy, K.R. Prabhakar, S. Menasinakai, S. Rudrapatna, M. Chatterji, M.B. Jimenez-Diaz, M.S. Martinez, L.M. Sanz, O. Coburn-Flynn, D.A. Fidock, A.K. Lukens, D.F. Wirth, B. Bandodkar, K. Mukherjee, R.E. McLaughlin, D. Waterson, L. Rosenbrier-Ribeiro, K. Hickling, V. Balasubramanian, P. Warner, V. Hosagrahara, A. Dudley, P.S. Iyer, S. Narayanan, S. Kavanagh, and V.K. Sambandamurthy. 2015. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. Nature Communications 6: 6715.","journal-title":"Nature Communications"},{"key":"645_CR43","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","volume":"112","author":"MB Harbut","year":"2015","unstructured":"Harbut, M.B., C. Vilcheze, X. Luo, M.E. Hensler, H. Guo, B. Yang, A.K. Chatterjee, V. Nizet, W.R. Jacobs Jr, P.G. Schultz, and F. Wang. 2015. Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proceedings of the National Academy of Sciences USA 112: 4453\u20134458.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nchembio.1405","volume":"10","author":"RC Hartkoorn","year":"2014","unstructured":"Hartkoorn, R.C., F. Pojer, J.A. Read, H. Gingell, J. Neres, O.P. Horlacher, K.H. Altmann, and S.T. Cole. 2014. Pyridomycin bridges the NADH- and substrate-binding pockets of the enoyl reductase InhA. Nature Chemical Biology 10: 96\u201398.","journal-title":"Nature Chemical Biology"},{"key":"645_CR45","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/emmm.201201689","volume":"4","author":"RC Hartkoorn","year":"2012","unstructured":"Hartkoorn, R.C., C. Sala, J. Neres, F. Pojer, S. Magnet, R. Mukherjee, S. Uplekar, S. Boy-Rottger, K.H. Altmann, and S.T. Cole. 2012. Towards a new tuberculosis drug: Pyridomycin\u2014nature\u2019s isoniazid. EMBO Molecular Medicine 4: 1032\u20131042.","journal-title":"EMBO Molecular Medicine"},{"key":"645_CR46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/13543784.2015.1000483","volume":"24","author":"J Held","year":"2015","unstructured":"Held, J., S. Jeyaraj, and A. Kreidenweiss. 2015. Antimalarial compounds in Phase II clinical development. Expert Opinion on Investigational Drugs 24: 363\u2013382.","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"645_CR47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins, A.L., and C.R. Groom. 2002. The druggable genome. Nature Reviews Drug Discovery 1: 727\u2013730.","journal-title":"Nature Reviews Drug Discovery"},{"key":"645_CR48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.exppara.2008.10.008","volume":"121","author":"S Izumiyama","year":"2009","unstructured":"Izumiyama, S., M. Omura, T. Takasaki, H. Ohmae, and H. Asahi. 2009. Plasmodium falciparum: Development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer. Experimental Parasitology 121: 144\u2013150.","journal-title":"Experimental Parasitology"},{"key":"645_CR49","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","volume":"111","author":"MB Jimenez-Diaz","year":"2014","unstructured":"Jimenez-Diaz, M.B., D. Ebert, Y. Salinas, A. Pradhan, A.M. Lehane, M.E. Myrand-Lapierre, K.G. O\u2019Loughlin, D.M. Shackleford, M. Justino de Almeida, A.K. Carrillo, J.A. Clark, A.S. Dennis, J. Diep, X. Deng, S. Duffy, A.N. Endsley, G. Fedewa, W.A. Guiguemde, M.G. Gomez, G. Holbrook, J. Horst, C.C. Kim, J. Liu, M.C. Lee, A. Matheny, M.S. Martinez, G. Miller, A. Rodriguez-Alejandre, L. Sanz, M. Sigal, N.J. Spillman, P.D. Stein, Z. Wang, F. Zhu, D. Waterson, S. Knapp, A. Shelat, V.M. Avery, D.A. Fidock, F.J. Gamo, S.A. Charman, J.C. Mirsalis, H. Ma, S. Ferrer, K. Kirk, I. Angulo-Barturen, D.E. Kyle, J.L. DeRisi, D.M. Floyd, and R.K. Guy. 2014. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proceedings of the National Academy of Sciences USA 111: E5455\u2013E5462.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR50","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson, J.D., R.A. Dennull, L. Gerena, M. Lopez-Sanchez, N.E. Roncal, and N.C. Waters. 2007. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrobial Agents and Chemotherapy 51: 1926\u20131933.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR51","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1126\/science.1167983","volume":"323","author":"MC Jonikas","year":"2009","unstructured":"Jonikas, M.C., S.R. Collins, V. Denic, E. Oh, E.M. Quan, V. Schmid, J. Weibezahn, B. Schwappach, P. Walter, J.S. Weissman, and M. Schuldiner. 2009. Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum. Science 323: 1693\u20131697.","journal-title":"Science"},{"key":"645_CR52","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1126\/science.1070633","volume":"296","author":"T Kaeberlein","year":"2002","unstructured":"Kaeberlein, T., K. Lewis, and S.S. Epstein. 2002. Isolating \u201cuncultivable\u201d microorganisms in pure culture in a simulated natural environment. Science 296: 1127\u20131129.","journal-title":"Science"},{"key":"645_CR53","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1021\/jm5003606","volume":"57","author":"S Kang","year":"2014","unstructured":"Kang, S., R.Y. Kim, M.J. Seo, S. Lee, Y.M. Kim, M. Seo, J.J. Seo, Y. Ko, I. Choi, J. Jang, J. Nam, S. Park, H. Kang, H.J. Kim, J. Kim, S. Ahn, K. Pethe, K. Nam, and Z. No. 2014. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent. Journal of Medicinal Chemistry 57: 5293\u20135305.","journal-title":"Journal of Medicinal Chemistry"},{"key":"645_CR54","doi-asserted-by":"crossref","first-page":"e87834","DOI":"10.1371\/journal.pone.0087834","volume":"9","author":"S Kicka","year":"2014","unstructured":"Kicka, S., V. Trofimov, C. Harrison, H. Ouertatani-Sakouhi, J. McKinney, L. Scapozza, H. Hilbi, P. Cosson, and T. Soldati. 2014. Establishment and validation of whole-cell based fluorescence assays to identify anti-mycobacterial compounds using the Acanthamoeba castellanii-Mycobacterium marinum host-pathogen system. PLoS ONE 9: e87834.","journal-title":"PLoS ONE"},{"key":"645_CR55","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1128\/AAC.00708-11","volume":"55","author":"JS Kim","year":"2011","unstructured":"Kim, J.S., P. Heo, T.J. Yang, K.S. Lee, D.H. Cho, B.T. Kim, J.H. Suh, H.J. Lim, D. Shin, S.K. Kim, and D.H. Kweon. 2011. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrobial Agents and Chemotherapy 55: 5380\u20135383.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR56","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens, R.M., M.A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J.M. Townes, A.S. Craig, E.R. Zell, G.E. Fosheim, L.K. McDougal, R.B. Carey, S.K. Fridkin, and Active Bacterial Core surveillance MI. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763\u20131771.","journal-title":"JAMA"},{"key":"645_CR57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","volume":"130","author":"MA Kohanski","year":"2007","unstructured":"Kohanski, M.A., D.J. Dwyer, B. Hayete, C.A. Lawrence, and J.J. Collins. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797\u2013810.","journal-title":"Cell"},{"key":"645_CR58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2010.02.012","volume":"140","author":"D Kumar","year":"2010","unstructured":"Kumar, D., L. Nath, M.A. Kamal, A. Varshney, A. Jain, S. Singh, and K.V. Rao. 2010. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140: 731\u2013743.","journal-title":"Cell"},{"key":"645_CR59","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.03478-14","volume":"58","author":"FJ Leong","year":"2014","unstructured":"Leong, F.J., R. Zhao, S. Zeng, B. Magnusson, T.T. Diagana, and P. Pertel. 2014. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrobial Agents and Chemotherapy 58: 6437\u20136443.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L.L., T. Schneider, A.J. Peoples, A.L. Spoering, I. Engels, B.P. Conlon, A. Mueller, T.F. Schaberle, DE Hughes, S. Epstein, M. Jones, L. Lazarides, V.A. Steadman, Cohen, C.R. Felix, K.A. Fetterman, W.P. Millett, A.G. Nitti, A.M. Zullo, C. Chen, and K. Lewis. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517: 455\u2013459.","journal-title":"Nature"},{"key":"645_CR61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1747-0285.2006.00389.x","volume":"67","author":"ZB Mackey","year":"2006","unstructured":"Mackey, Z.B., A.M. Baca, J.P. Mallari, B. Apsel, A. Shelat, E.J. Hansell, P.K. Chiang, B. Wolff, K.R. Guy, J. Williams, and J.H. McKerrow. 2006. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chemical Biology & Drug Design 67: 355\u2013363.","journal-title":"Chemical Biology & Drug Design"},{"key":"645_CR62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","volume":"324","author":"V Makarov","year":"2009","unstructured":"Makarov, V., G. Manina, K. Mikusova, U. Mollmann, O. Ryabova, B. Saint-Joanis, N. Dhar, M.R. Pasca, S. Buroni, A.P. Lucarelli, A. Milano, E. De Rossi, M. Belanova, A. Bobovska, P. Dianiskova, J. Kordulakova, C. Sala, E. Fullam, P. Schneider, J.D. McKinney, P. Brodin, T. Christophe, S. Waddell, P. Butcher, J. Albrethsen, I. Rosenkrands, R. Brosch, V. Nandi, S. Bharath, S. Gaonkar, R.K. Shandil, V. Balasubramanian, T. Balganesh, S. Tyagi, J. Grosset, G. Riccardi, and S.T. Cole. 2009. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. Science 324: 801\u2013804.","journal-title":"Science"},{"key":"645_CR63","first-page":"511","volume":"65","author":"L Malone","year":"1952","unstructured":"Malone, L., A. Schurr, H. Lindh, K.D. Mc, J.S. Kiser, and J.H. Williams. 1952. The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice. American Review of Tuberculosis 65: 511\u2013518.","journal-title":"American Review of Tuberculosis"},{"key":"645_CR64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","volume":"17","author":"G Manina","year":"2015","unstructured":"Manina, G., N. Dhar, and J.D. McKinney. 2015. Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host & Microbe 17: 32\u201346.","journal-title":"Cell Host & Microbe"},{"key":"645_CR65","doi-asserted-by":"crossref","first-page":"269ra263","DOI":"10.1126\/scitranslmed.3010597","volume":"7","author":"UH Manjunatha","year":"2015","unstructured":"Manjunatha, U.H., S.P. Rao, R.R. Kondreddi, C.G. Noble, L.R. Camacho, B.H. Tan, S.H. Ng, P.S. Ng, N.L. Miia, S.B. Lakshminarayana, M. Herve, S.W. Barnes, W. Yu, K. Kuhen, F. Blasco, D. Beer, J.R. Walker, P.J. Tonge, R. Glynne, P.W. Smith, and T.T. Diagana. 2015. Direct inhibitors of InhA are active against Mycobacterium tuberculosis. Science translational medicine 7: 269ra263.","journal-title":"Science translational medicine"},{"key":"645_CR66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","volume":"14","author":"S March","year":"2013","unstructured":"March, S., S. Ng, S. Velmurugan, A. Galstian, J. Shan, D.J. Logan, A.E. Carpenter, D. Thomas, B.K. Sim, M.M. Mota, S.L. Hoffman, and S.N. Bhatia. 2013. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host & Microbe 14: 104\u2013115.","journal-title":"Cell Host & Microbe"},{"key":"645_CR67","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1371\/journal.pmed.0030466","volume":"3","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto, M., H. Hashizume, T. Tomishige, M. Kawasaki, H. Tsubouchi, H. Sasaki, Y. Shimokawa, and M. Komatsu. 2006. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Medicine 3: e466.","journal-title":"PLoS Medicine"},{"key":"645_CR68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/JB.02352-14","volume":"197","author":"SM McLeod","year":"2015","unstructured":"McLeod, S.M., P.R. Fleming, K. MacCormack, R.E. McLaughlin, J.D. Whiteaker, S.I. Narita, M. Mori, H. Tokuda, and A.A. Miller. 2015. Small molecule inhibitors of Gram-negative lipoprotein trafficking discovered by phenotypic screening. Journal of Bacteriology 197: 1075\u20131082.","journal-title":"Journal of Bacteriology"},{"key":"645_CR69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","volume":"334","author":"S Meister","year":"2011","unstructured":"Meister, S., D.M. Plouffe, K.L. Kuhen, G.M. Bonamy, T. Wu, S.W. Barnes, S.E. Bopp, R. Borboa, A.T. Bright, J. Che, S. Cohen, N.V. Dharia, K. Gagaring, M. Gettayacamin, P. Gordon, T. Groessl, N. Kato, M.C. Lee, C.W. McNamara, D.A. Fidock, A. Nagle, T.G. Nam, W. Richmond, J. Roland, M. Rottmann, B. Zhou, P. Froissard, R.J. Glynne, D. Mazier, J. Sattabongkot, P.G. Schultz, T. Tuntland, J.R. Walker, Y. Zhou, A. Chatterjee, T.T. Diagana, and E.A. Winzeler. 2011. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334: 1372\u20131377.","journal-title":"Science"},{"key":"645_CR70","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1073\/pnas.0811275106","volume":"106","author":"JR Miller","year":"2009","unstructured":"Miller, J.R., S. Dunham, I. Mochalkin, C. Banotai, M. Bowman, S. Buist, B. Dunkle, D. Hanna, H.J. Harwood, M.D. Huband, A. Karnovsky, M. Kuhn, C. Limberakis, J.Y. Liu, S. Mehrens, W.T. Mueller, L. Narasimhan, A. Ogden, J. Ohren, J.V. Prasad, J.A. Shelly, L. Skerlos, M. Sulavik, V.H. Thomas, S. VanderRoest, L. Wang, Z. Wang, A. Whitton, T. Zhu, and C.K. Stover. 2009. A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore. Proceedings of the National Academy of Sciences USA 106: 1737\u20131742.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR71","doi-asserted-by":"crossref","first-page":"e87188","DOI":"10.1371\/journal.pone.0087188","volume":"9","author":"S Moon","year":"2014","unstructured":"Moon, S., J.L. Siqueira-Neto, C.B. Moraes, G. Yang, M. Kang, L.H. Freitas-Junior, and M.A. Hansen. 2014. An image-based algorithm for precise and accurate high throughput assessment of drug activity against the human parasite Trypanosoma cruzi. PLoS ONE 9: e87188.","journal-title":"PLoS ONE"},{"key":"645_CR72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/ml200036r","volume":"2","author":"GC Moraski","year":"2011","unstructured":"Moraski, G.C., L.D. Markley, P.A. Hipskind, H. Boshoff, S. Cho, S.G. Franzblau, and M.J. Miller. 2011. Advent of imidazo[1,2-a]pyridine-3-carboxamides with potent multi- and extended drug resistant antituberculosis activity. ACS Medicinal Chemistry Letters 2: 466\u2013470.","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"645_CR73","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.chembiol.2014.08.020","volume":"21","author":"P Murima","year":"2014","unstructured":"Murima, P., J.D. McKinney, and K. Pethe. 2014. Targeting bacterial central metabolism for drug development. Chemistry & Biology 21: 1423\u20131432.","journal-title":"Chemistry & Biology"},{"key":"645_CR74","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1128\/AEM.01754-09","volume":"76","author":"D Nichols","year":"2010","unstructured":"Nichols, D., N. Cahoon, E.M. Trakhtenberg, L. Pham, A. Mehta, A. Belanger, T. Kanigan, K. Lewis, and S.S. Epstein. 2010. Use of ichip for high-throughput in situ cultivation of \u201cuncultivable\u201d microbial species. Applied and Environment Microbiology 76: 2445\u20132450.","journal-title":"Applied and Environment Microbiology"},{"key":"645_CR75","doi-asserted-by":"crossref","first-page":"e962","DOI":"10.1371\/journal.pntd.0000962","volume":"5","author":"Y Osorio","year":"2011","unstructured":"Osorio, Y., B.L. Travi, A.R. Renslo, A.G. Peniche, and P.C. Melby. 2011. Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system. PLOS Neglected Tropical Diseases 5: e962.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"645_CR76","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D.J., M.N. Gwynn, D.J. Holmes, and D.L. Pompliano. 2007. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery 6: 29\u201340.","journal-title":"Nature Reviews Drug Discovery"},{"key":"645_CR77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2015.01.008","volume":"21","author":"B Peng","year":"2015","unstructured":"Peng, B., Y.B. Su, H. Li, Y. Han, C. Guo, Y.M. Tian, and X.X. Peng. 2015. Exogenous alanine and\/or glucose plus kanamycin kills antibiotic-resistant bacteria. Cell Metabolism 21: 249\u2013261.","journal-title":"Cell Metabolism"},{"key":"645_CR78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.00887-13","volume":"58","author":"AG Peniche","year":"2014","unstructured":"Peniche, A.G., Y. Osorio, A.R. Renslo, D.E. Frantz, P.C. Melby, and B.L. Travi. 2014. Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major. Antimicrobial Agents and Chemotherapy 58: 78\u201387.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR79","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","volume":"19","author":"K Pethe","year":"2013","unstructured":"Pethe, K., P. Bifani, J. Jang, S. Kang, S. Park, S. Ahn, J. Jiricek, J. Jung, H.K. Jeon, J. Cechetto, T. Christophe, H. Lee, M. Kempf, M. Jackson, A.J. Lenaerts, H. Pham, V. Jones, M.J. Seo, Y.M. Kim, M. Seo, J.J. Seo, D. Park, Y. Ko, I. Choi, R. Kim, S.Y. Kim, S. Lim, S.A. Yim, J. Nam, H. Kang, H. Kwon, C.T. Oh, Y. Cho, Y. Jang, J. Kim, A. Chua, B.H. Tan, M.B. Nanjundappa, S.P. Rao, W.S. Barnes, R. Wintjens, J.R. Walker, S. Alonso, S. Lee, S. Oh, T. Oh, U. Nehrbass, S.J. Han, Z. No, J. Lee, P. Brodin, S.N. Cho, and K. Nam. 2013. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nature Medicine 19: 1157\u20131160.","journal-title":"Nature Medicine"},{"key":"645_CR80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ncomms1060","volume":"1","author":"K Pethe","year":"2010","unstructured":"Pethe, K., P.C. Sequeira, S. Agarwalla, K. Rhee, K. Kuhen, W.Y. Phong, V. Patel, D. Beer, J.R. Walker, J. Duraiswamy, J. Jiricek, T.H. Keller, A. Chatterjee, M.P. Tan, M. Ujjini, S.P. Rao, L. Camacho, P. Bifani, P.A. Mak, I. Ma, S.W. Barnes, Z. Chen, D. Plouffe, P. Thayalan, S.H. Ng, M. Au, B.H. Lee, B.H. Tan, S. Ravindran, M. Nanjundappa, X. Lin, A. Goh, S.B. Lakshminarayana, C. Shoen, M. Cynamon, B. Kreiswirth, V. Dartois, E.C. Peters, R. Glynne, S. Brenner, and T. Dick. 2010. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nature Communications 1: 57.","journal-title":"Nature Communications"},{"key":"645_CR81","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","volume":"105","author":"D Plouffe","year":"2008","unstructured":"Plouffe, D., A. Brinker, C. McNamara, K. Henson, N. Kato, K. Kuhen, A. Nagle, F. Adri\u00e1n, J.T. Matzen, P. Anderson, T.G. Nam, N.S. Gray, A. Chatterjee, J. Janes, S.F. Yan, R. Trager, J.S. Caldwell, P.G. Schultz, Y. Zhou, and E.A. Winzeler. 2008. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proceedings of the National Academy of Sciences USA 105: 9059\u20139064.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR82","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1021\/jm500715u","volume":"57","author":"S Ramachandran","year":"2014","unstructured":"Ramachandran, S., P.S. Hameed, A. Srivastava, G. Shanbhag, S. Morayya, N. Rautela, D. Awasthy, S. Kavanagh, S. Bharath, J. Reddy, V. Panduga, K.R. Prabhakar, R. Saralaya, R. Nanduri, A. Raichurkar, S. Menasinakai, V. Achar, M.B. Jimenez-Diaz, M.S. Martinez, I. Angulo-Barturen, S. Ferrer, L.M. Sanz, F.J. Gamo, S. Duffy, V.M. Avery, D. Waterson, M.C. Lee, O. Coburn-Flynn, D.A. Fidock, P.S. Iyer, S. Narayanan, V. Hosagrahara, and V.K. Sambandamurthy. 2014. N-aryl-2-aminobenzimidazoles: Novel, efficacious, antimalarial lead compounds. Journal of Medicinal Chemistry 57: 6642\u20136652.","journal-title":"Journal of Medicinal Chemistry"},{"key":"645_CR83","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1099\/00221287-147-4-1017","volume":"147","author":"M Rao","year":"2001","unstructured":"Rao, M., T.L. Streur, F.E. Aldwell, and G.M. Cook. 2001. Intracellular pH regulation by Mycobacterium smegmatis and Mycobacterium bovis BCG. Microbiology 147: 1017\u20131024.","journal-title":"Microbiology"},{"key":"645_CR84","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","volume":"105","author":"SP Rao","year":"2008","unstructured":"Rao, S.P., S. Alonso, L. Rand, T. Dick, and K. Pethe. 2008. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences USA 105: 11945\u201311950.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"645_CR85","doi-asserted-by":"crossref","first-page":"214ra168","DOI":"10.1126\/scitranslmed.3007355","volume":"5","author":"SP Rao","year":"2013","unstructured":"Rao, S.P., S.B. Lakshminarayana, R.R. Kondreddi, M. Herve, L.R. Camacho, P. Bifani, S.K. Kalapala, J. Jiricek, N.L. Ma, B.H. Tan, S.H. Ng, M. Nanjundappa, S. Ravindran, P.G. Seah, P. Thayalan, S.H. Lim, B.H. Lee, A. Goh, W.S. Barnes, Z. Chen, K. Gagaring, A.K. Chatterjee, K. Pethe, K. Kuhen, J. Walker, G. Feng, S. Babu, L. Zhang, F. Blasco, D. Beer, M. Weaver, V. Dartois, R. Glynne, T. Dick, P.W. Smith, T.T. Diagana, and U.H. Manjunatha. 2013. Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Science Translational Medicine 5: 214ra168.","journal-title":"Science Translational Medicine"},{"key":"645_CR86","first-page":"355","volume":"4","author":"RM Reguera","year":"2014","unstructured":"Reguera, R.M., E. Calvo-\u00c1lvarez, R. Alvarez-Velilla, and R. Bala\u00f1a-Fouce. 2014. Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf? International Journal for Parasitology: Drugs and Drug Resistance 4: 355\u2013357.","journal-title":"International Journal for Parasitology: Drugs and Drug Resistance"},{"key":"645_CR87","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L.B. 2008. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. Journal of Infectious Diseases 197: 1079\u20131081.","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"645_CR88","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/655995","volume":"31","author":"LB Rice","year":"2010","unstructured":"Rice, L.B. 2010. Progress and challenges in implementing the research on ESKAPE pathogens. Infection Control and Hospital Epidemiology 31(Suppl 1): S7\u2013S10.","journal-title":"Infection Control and Hospital Epidemiology"},{"key":"645_CR89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pt.2011.12.003","volume":"28","author":"A Rodriguez","year":"2012","unstructured":"Rodriguez, A., and R.L. Tarleton. 2012. Transgenic parasites accelerate drug discovery. Trends in Parasitology 28: 90\u201392.","journal-title":"Trends in Parasitology"},{"key":"645_CR90","doi-asserted-by":"crossref","first-page":"e1002769","DOI":"10.1371\/journal.ppat.1002769","volume":"8","author":"KH Rohde","year":"2012","unstructured":"Rohde, K.H., D.F. Veiga, S. Caldwell, G. Balazsi, and D.G. Russell. 2012. Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathogens 8: e1002769.","journal-title":"PLoS Pathogens"},{"key":"645_CR91","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M., C. McNamara, B.K. Yeung, M.C. Lee, B. Zou, B. Russell, P. Seitz, D.M. Plouffe, N.V. Dharia, J. Tan, S.B. Cohen, K.R. Spencer, G.E. Gonzalez-Paez, S.B. Lakshminarayana, A. Goh, R. Suwanarusk, T. Jegla, E.K. Schmitt, H.P. Beck, R. Brun, F. Nosten, L. Renia, V. Dartois, T.H. Keller, D.A. Fidock, E.A. Winzeler, and T.T. Diagana. 2010. Spiroindolones, a potent compound class for the treatment of malaria. Science 329: 1175\u20131180.","journal-title":"Science"},{"key":"645_CR92","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.chom.2014.09.008","volume":"16","author":"J Rybniker","year":"2014","unstructured":"Rybniker, J., J.M. Chen, C. Sala, R.C. Hartkoorn, A. Vocat, A. Benjak, S. Boy-Rottger, M. Zhang, R. Szekely, Z. Greff, L. Orfi, I. Szabadkai, J. Pato, G. Keri, and S.T. Cole. 2014. Anticytolytic screen identifies inhibitors of mycobacterial virulence protein secretion. Cell Host & Microbe 16: 538\u2013548.","journal-title":"Cell Host & Microbe"},{"key":"645_CR93","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","volume":"6","author":"J Rybniker","year":"2015","unstructured":"Rybniker, J., A. Vocat, C. Sala, P. Busso, F. Pojer, A. Benjak, and S.T. Cole. 2015. Lansoprazole is an antituberculous prodrug targeting cytochrome bc1. Nature Communications 6: 7659.","journal-title":"Nature Communications"},{"key":"645_CR94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6446(04)03316-1","volume":"10","author":"F Sams-Dodd","year":"2005","unstructured":"Sams-Dodd, F. 2005. Target-based drug discovery: Is something wrong? Drug Discovery Today 10: 139\u2013147.","journal-title":"Drug Discovery Today"},{"key":"645_CR95","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1128\/AAC.05188-11","volume":"55","author":"LM Sanz","year":"2011","unstructured":"Sanz, L.M., M.B. Jimenez-Diaz, B. Crespo, C. De-Cozar, M.J. Almela, I. Angulo-Barturen, P. Castaneda, J. Ibanez, E.P. Fernandez, S. Ferrer, E. Herreros, S. Lozano, M.S. Martinez, L. Rueda, J.N. Burrows, J.F. Garcia-Bustos, and F.J. Gamo. 2011. Cyclopropyl carboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screen. Antimicrobial Agents and Chemotherapy 55: 5740\u20135745.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR96","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/JB.180.7.1869-1877.1998","volume":"180","author":"C Scharf","year":"1998","unstructured":"Scharf, C., S. Riethdorf, H. Ernst, S. Engelmann, U. Volker, and M. Hecker. 1998. Thioredoxin is an essential protein induced by multiple stresses in Bacillus subtilis. Journal of Bacteriology 180: 1869\u20131877.","journal-title":"Journal of Bacteriology"},{"key":"645_CR97","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.1164571","volume":"322","author":"R Singh","year":"2008","unstructured":"Singh, R., U. Manjunatha, H.I. Boshoff, Y.H. Ha, P. Niyomrattanakit, R. Ledwidge, C.S. Dowd, I.Y. Lee, P. Kim, L. Zhang, S. Kang, T.H. Keller, J. Jiricek, and C.E. Barry 3rd. 2008. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322: 1392\u20131395.","journal-title":"Science"},{"key":"645_CR98","doi-asserted-by":"crossref","first-page":"e1671","DOI":"10.1371\/journal.pntd.0001671","volume":"6","author":"JL Siqueira-Neto","year":"2012","unstructured":"Siqueira-Neto, J.L., S. Moon, J. Jang, G. Yang, C. Lee, H.K. Moon, E. Chatelain, A. Genovesio, J. Cechetto, and L.H. Freitas-Junior. 2012. An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLOS Neglected Tropical Diseases 6: e1671.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"645_CR99","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., N. Sriwilaijaroen, J.X. Kelly, P. Wilairat, and M. Riscoe. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrobial Agents and Chemotherapy 48: 1803\u20131806.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","volume":"13","author":"NJ Spillman","year":"2013","unstructured":"Spillman, N.J., R.J. Allen, C.W. McNamara, B.K. Yeung, E.A. Winzeler, T.T. Diagana, and K. Kirk. 2013. Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host & Microbe 13: 227\u2013237.","journal-title":"Cell Host & Microbe"},{"key":"645_CR101","doi-asserted-by":"crossref","first-page":"e1003946","DOI":"10.1371\/journal.ppat.1003946","volume":"10","author":"SA Stanley","year":"2014","unstructured":"Stanley, S.A., A.K. Barczak, M.R. Silvis, S.S. Luo, K. Sogi, M. Vokes, M.A. Bray, A.E. Carpenter, C.B. Moore, N. Siddiqi, E.J. Rubin, and D.T. Hung. 2014. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathogens 10: e1003946.","journal-title":"PLoS Pathogens"},{"key":"645_CR102","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","volume":"405","author":"CK Stover","year":"2000","unstructured":"Stover, C.K., P. Warrener, D.R. VanDevanter, D.R. Sherman, T.M. Arain, M.H. Langhorne, S.W. Anderson, J.A. Towell, Y. Yuan, D.N. McMurray, B.N. Kreiswirth, C.E. Barry, and W.R. Baker. 2000. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405: 962\u2013966.","journal-title":"Nature"},{"key":"645_CR103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.chom.2013.01.008","volume":"13","author":"V Sundaramurthy","year":"2013","unstructured":"Sundaramurthy, V., R. Barsacchi, N. Samusik, G. Marsico, J. Gilleron, I. Kalaidzidis, F. Meyenhofer, M. Bickle, Y. Kalaidzidis, and M. Zerial. 2013. Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host & Microbe 13: 129\u2013142.","journal-title":"Cell Host & Microbe"},{"key":"645_CR104","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1128\/IAI.00887-06","volume":"74","author":"LE Swaim","year":"2006","unstructured":"Swaim, L.E., L.E. Connolly, H.E. Volkman, O. Humbert, D.E. Born, and L. Ramakrishnan. 2006. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infection and Immunity 74: 6108\u20136117.","journal-title":"Infection and Immunity"},{"key":"645_CR105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","volume":"93","author":"DC Swinney","year":"2013","unstructured":"Swinney, D.C. 2013. Phenotypic vs. target-based drug discovery for first-in-class medicines. Clinical Pharmacology and Therapeutics 93: 299\u2013301.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"645_CR106","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4269\/ajtmh.2009.09-0015","volume":"81","author":"ML Sykes","year":"2009","unstructured":"Sykes, M.L., and V.M. Avery. 2009a. Development of an alamar blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. American Journal of Tropical Medicine and Hygeine 81: 665\u2013674.","journal-title":"American Journal of Tropical Medicine and Hygeine"},{"key":"645_CR107","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-3305-2-54","volume":"2","author":"ML Sykes","year":"2009","unstructured":"Sykes, M.L., and V.M. Avery. 2009b. A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. Parasit Vectors 2: 54.","journal-title":"Parasit Vectors"},{"key":"645_CR108","doi-asserted-by":"crossref","first-page":"e1896","DOI":"10.1371\/journal.pntd.0001896","volume":"6","author":"ML Sykes","year":"2012","unstructured":"Sykes, M.L., J.B. Baell, M. Kaiser, E. Chatelain, S.R. Moawad, D. Ganame, J.R. Ioset, and V.M. Avery. 2012. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. PLOS Neglected Tropical Diseases 6: e1896.","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"645_CR109","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.celrep.2012.06.008","volume":"2","author":"K Takaki","year":"2012","unstructured":"Takaki, K., C.L. Cosma, M.A. Troll, and L. Ramakrishnan. 2012. An in vivo platform for rapid high-throughput antitubercular drug discovery. Cell Reports 2: 175\u2013184.","journal-title":"Cell Reports"},{"key":"645_CR110","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nprot.2013.068","volume":"8","author":"K Takaki","year":"2013","unstructured":"Takaki, K., J.M. Davis, K. Winglee, and L. Ramakrishnan. 2013. Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish. Nature Protocols 8: 1114\u20131124.","journal-title":"Nature Protocols"},{"key":"645_CR111","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-2275(20)36719-5","volume":"16","author":"K Takayama","year":"1975","unstructured":"Takayama, K., H.K. Schnoes, E.L. Armstrong, and R.W. Boyle. 1975. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. Journal of Lipid Research 16: 308\u2013317.","journal-title":"Journal of Lipid Research"},{"key":"645_CR112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.03822-14","volume":"59","author":"R Tasneen","year":"2015","unstructured":"Tasneen, R., K. Williams, O. Amoabeng, A. Minkowski, K.E. Mdluli, A.M. Upton, and E.L. Nuermberger. 2015. Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis. Antimicrobial Agents and Chemotherapy 59: 129\u2013135.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"645_CR113","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd2410","volume":"6","author":"GC Terstappen","year":"2007","unstructured":"Terstappen, G.C., C. Schlupen, R. Raggiaschi, and G. Gaviraghi. 2007. Target deconvolution strategies in drug discovery. Nature Reviews Drug Discovery 6: 891\u2013903.","journal-title":"Nature Reviews Drug Discovery"},{"key":"645_CR114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun, K.M., M. Imwong, K.M. Lwin, A.A. Win, T.M. Hlaing, T. Hlaing, K. Lin, M.P. Kyaw, K. Plewes, M.A. Faiz, M. Dhorda, P.Y. Cheah, S. Pukrittayakamee, E.A. Ashley, T.J. Anderson, S. Nair, M. McDew-White, J.A. Flegg, E.P. Grist, P. Guerin, R.J. Maude, F. Smithuis, A.M. Dondorp, N.P. Day, F. Nosten, N.J. White, and C.J. Woodrow. 2015. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. The Lancet Infectious Diseases 15: 415\u2013421.","journal-title":"The Lancet Infectious Diseases"},{"key":"645_CR115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/JB.186.2.326-334.2004","volume":"186","author":"O Uziel","year":"2004","unstructured":"Uziel, O., I. Borovok, R. Schreiber, G. Cohen, and Y. Aharonowitz. 2004. Transcriptional regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase genes in response to oxygen and disulfide stress. Journal of Bacteriology 186: 326\u2013334.","journal-title":"Journal of Bacteriology"},{"key":"645_CR116","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","volume":"5","author":"AB Vaidya","year":"2014","unstructured":"Vaidya, A.B., J.M. Morrisey, Z. Zhang, S. Das, T.M. Daly, T.D. Otto, N.J. Spillman, M. Wyvratt, P. Siegl, J. Marfurt, G. Wirjanata, B.F. Sebayang, R.N. Price, A. Chatterjee, A. Nagle, M. Stasiak, S.A. Charman, I. Angulo-Barturen, S. Ferrer, M. Belen Jimenez-Diaz, M.S. Martinez, F.J. Gamo, V.M. Avery, A. Ruecker, M. Delves, K. Kirk, M. Berriman, S. Kortagere, J. Burrows, E. Fan, and L.W. Bergman. 2014. Pyrazoleamide compounds are potent antimalarials that target Na\u00a0+\u00a0homeostasis in intraerythrocytic Plasmodium falciparum. Nat Commun 5: 5521.","journal-title":"Nat Commun"},{"key":"645_CR117","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden, M.G. 2011. Targeting cancer metabolism: A therapeutic window opens. Nature Reviews Drug Discovery 10: 671\u2013684.","journal-title":"Nature Reviews Drug Discovery"},{"key":"645_CR118","doi-asserted-by":"crossref","first-page":"e1004679","DOI":"10.1371\/journal.ppat.1004679","volume":"11","author":"BC VanderVen","year":"2015","unstructured":"VanderVen, B.C., R.J. Fahey, W. Lee, Y. Liu, R.B. Abramovitch, C. Memmott, A.M. Crowe, L.D. Eltis, E. Perola, D.D. Deininger, T. Wang, C.P. Locher, and D.G. Russell. 2015. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium\u2019s metabolism is constrained by the intracellular environment. PLoS Pathogens 11: e1004679.","journal-title":"PLoS Pathogens"},{"key":"645_CR119","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","volume":"144","author":"R Viotti","year":"2006","unstructured":"Viotti, R., C. Vigliano, B. Lococo, G. Bertocchi, M. Petti, M.G. Alvarez, M. Postan, and A. Armenti. 2006. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial. Annals of Internal Medicine 144: 724\u2013734.","journal-title":"Annals of Internal Medicine"},{"key":"645_CR120","doi-asserted-by":"crossref","first-page":"e54888","DOI":"10.1371\/journal.pone.0054888","volume":"8","author":"A Voorberg-van der Wel","year":"2013","unstructured":"Voorberg-van der Wel, A., A.M. Zeeman, S.M. van Amsterdam, A. van den Berg, E.J. Klooster, S. Iwanaga, C.J. Janse, G.J. van Gemert, R. Sauerwein, N. Beenhakker, G. Koopman, A.W. Thomas, and C.H. Kocken. 2013. Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms. PLoS ONE 8: e54888.","journal-title":"PLoS ONE"},{"key":"645_CR121","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4269\/ajtmh.2010.09-0417","volume":"82","author":"MG Vossen","year":"2010","unstructured":"Vossen, M.G., S. Pferschy, P. Chiba, and H. Noedl. 2010. The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples. American Journal of Tropical Medicine and Hygeine 82: 398\u2013401.","journal-title":"American Journal of Tropical Medicine and Hygeine"},{"key":"645_CR122","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.1229858","volume":"339","author":"Y Wakamoto","year":"2013","unstructured":"Wakamoto, Y., N. Dhar, R. Chait, K. Schneider, F. Signorino-Gelo, S. Leibler, and J.D. McKinney. 2013. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339: 91\u201395.","journal-title":"Science"},{"key":"645_CR123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","volume":"26","author":"TN Wells","year":"2010","unstructured":"Wells, T.N., J.N. Burrows, and J.K. Baird. 2010. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends in Parasitology 26: 145\u2013151.","journal-title":"Trends in Parasitology"},{"key":"645_CR124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","volume":"371","author":"NJ White","year":"2014","unstructured":"White, N.J., S. Pukrittayakamee, A.P. Phyo, R. Rueangweerayut, F. Nosten, P. Jittamala, A. Jeeyapant, J.P. Jain, G. Lefevre, R. Li, B. Magnusson, T.T. Diagana, and F.J. Leong. 2014. Spiroindolone KAE609 for falciparum and vivax malaria. New England Journal of Medicine 371: 403\u2013410.","journal-title":"New England Journal of Medicine"},{"key":"645_CR125","unstructured":"WHO (2013) WHO Global Tuberculosis Report 2013. World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland, p. 306."},{"key":"645_CR126","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3201\/eid1405.071601","volume":"14","author":"C Wongsrichanalai","year":"2008","unstructured":"Wongsrichanalai, C., and S.R. Meshnick. 2008. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerging Infectious Diseases 14: 716\u2013719.","journal-title":"Emerging Infectious Diseases"},{"key":"645_CR127","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1021\/jm100410f","volume":"53","author":"BK Yeung","year":"2010","unstructured":"Yeung, B.K., B. Zou, M. Rottmann, S.B. Lakshminarayana, S.H. Ang, S.Y. Leong, J. Tan, J. Wong, S. Keller-Maerki, C. Fischli, A. Goh, E.K. Schmitt, P. Krastel, E. Francotte, K. Kuhen, D. Plouffe, K. Henson, T. Wagner, E.A. Winzeler, F. Petersen, R. Brun, V. Dartois, T.T. Diagana, and T.H. Keller. 2010. Spirotetrahydro beta-carbolines (spiroindolones): A new class of potent and orally efficacious compounds for the treatment of malaria. Journal of Medicinal Chemistry 53: 5155\u20135164.","journal-title":"Journal of Medicinal Chemistry"},{"key":"645_CR128","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nchembio.1361","volume":"9","author":"S Zlitni","year":"2013","unstructured":"Zlitni, S., L.F. Ferruccio, and E.D. Brown. 2013. Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation. Nature Chemical Biology 9: 796\u2013804.","journal-title":"Nature Chemical Biology"},{"key":"645_CR129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/ml500244m","volume":"5","author":"B Zou","year":"2014","unstructured":"Zou, B., A. Nagle, A.K. Chatterjee, S.Y. Leong, L.J. Tan, W.L. Sim, P. Mishra, P. Guntapalli, D.C. Tully, S.B. Lakshminarayana, C.S. Lim, Y.C. Tan, S.N. Abas, C. Bodenreider, K.L. Kuhen, K. Gagaring, R. Borboa, J. Chang, C. Li, T. Hollenbeck, T. Tuntland, A.M. Zeeman, C.H. Kocken, C. McNamara, N. Kato, E.A. Winzeler, B.K. Yeung, T.T. Diagana, P.W. Smith, and J. Roland. 2014. Lead optimization of imidazopyrazines: A new class of antimalarial with activity on Plasmodium liver stages. ACS Med Chem Lett 5: 947\u2013950.","journal-title":"ACS Med Chem Lett"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-015-0645-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0645-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:53:01Z","timestamp":1653018781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-015-0645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":129,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s12272-015-0645-0","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}